Provided by Tiger Fintech (Singapore) Pte. Ltd.

ViewRay

0.0250
0.0000
Volume:- -
Turnover:3.51M
Market Cap:4.59M
PE:-0.04
High:0.0250
Open:0.0250
Low:0.0250
Close:0.0250
Loading ...

Do You Believe in the Growth Prospects of ViewRay (VRAY)?

Insider Monkey
·
16 May 2023

ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting

PR Newswire
·
12 May 2023

ViewRay downgraded to neutral from buy at B. Riley

Dow Jones
·
11 May 2023

Q1 2023 ViewRay Inc Earnings Call

Thomson Reuters StreetEvents
·
11 May 2023

B.Riley Financial downgrades Viewray (VRAY) to a Hold

TIPRANKS
·
11 May 2023

BTIG Remains a Hold on Viewray (VRAY)

TIPRANKS
·
11 May 2023

ViewRay Withdraws Guidance for 2023

Dow Jones
·
11 May 2023

ViewRay (VRAY) Reports Q1 Loss, Misses Revenue Estimates

Zacks
·
11 May 2023

ViewRay Q1 EPS $(0.16), Inline, Sales $22.50M Miss $22.60M Estimate

Benzinga
·
11 May 2023

ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023

PR Newswire
·
10 May 2023

BRIEF-Farhad Fred Ebrahimi Reports 8.39% Stake In ViewRay Inc As Of April 14 - SEC Filing

Reuters
·
28 Apr 2023

ViewRay Is Maintained at Overweight by Piper Sandler

Dow Jones
·
24 Apr 2023

It's Down 63% But ViewRay, Inc. (NASDAQ:VRAY) Could Be Riskier Than It Looks

Simply Wall St.
·
17 Apr 2023

Jefferies downgrades Viewray (VRAY) to a Hold

TIPRANKS
·
17 Apr 2023

Wall Street analysts cut ViewRay (VRAY) following preliminary results

StreetInsider
·
15 Apr 2023

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Tonix Pharma (TNXP) and Viewray (VRAY)

TIPRANKS
·
14 Apr 2023

B. Riley Lowers ViewRay's Price Target to $4 From $8 After Softer-Than-Expected Q1 Revenue, Keeps Buy Rating

Marketscreener.com
·
14 Apr 2023

ViewRay downgraded to hold from buy at Stifel Nicolaus

Dow Jones
·
14 Apr 2023